
BLOOD STEM CELL
THERAPIES
Our platform technology for generating self-renewing blood stem cells is poised to provide patients with rapid and broad access to consistent, durable, HLA-compatible transgene-free blood stem cell therapies. As the industry’s first off-the-shelf offering, Garuda’s technology has the potential to cure more than 70 diseases and eliminate dependency on donor or patient cells.
LEADERSHIP
Garuda was founded and is supported by experts in blood stem cell and bone marrow transplants as well as leaders with expertise in bringing transformative medicines to patients.
Leadership Team

Dhvanit Shah, Ph.D.

James Desiderio, Ph.D.

Giorgia Scapin, Ph.D.

Roger Sawhney, M.D.
The Founders

Dhvanit Shah, Ph.D.
Former Principal Faculty,
Harvard Stem Cell Institute
Former Associate Member,
Broad Institute of MIT and Harvard

David Scadden, M.D.
Co-Director,
Harvard Stem Cell Institute
Gerald and Darlene Jordan
Professor of Medicine, Harvard University

Sean Morrison, Ph.D.
Investigator,
Howard Hughes Medical Institute
Director, Children’s Research Institute,
UT Southwestern Medical Center
Board of Directors

Dhvanit Shah, Ph.D.
Founder, President, and CEO
Garuda Therapeutics, Inc.

Eric Aguiar, M.D.
Partner
Aisling Capital

Carl Gordon, Ph.D., CFA
Managing Partner
OrbiMed

Shaan C. Gandhi, M.D., D.Phil.
Director
Northpond Ventures

Rahul Singhvi, Sc.D.
Co-Founder and CEO
National Resilience, Inc.

Laurence Reid, Ph.D.
CEO
Decibel Therapeutics
Scientific Advisory Board

David Scadden, M.D.
Co-Director, Harvard Stem Cell Institute
Gerald and Darlene Jordan Professor of Medicine, Harvard University

Sean Morrison, Ph.D.
Investigator, Howard Hughes Medical Institute
Founder & Director, Children’s Research Institute at UT Southwestern Medical Center

Robert Negrin, M.D.
Professor of Medicine, Stanford University
Former Chief of the Division of Blood and Marrow Transplantation, Stanford University

Jerome Ritz, M.D.
Executive Director, Connell and O’Reilly Families Cell Manipulation Core Facility, Dana-Farber Cancer Institute
Professor of Medicine, Harvard Medical School

Marcel van den Brink, M.D., Ph.D.
Head, Division of Hematologic Malignancies &
Alan N. Houghton Chair, Memorial Sloan Kettering Cancer Center

Ivan Maillard, M.D., Ph.D.
Professor of Hematology-Oncology, University of Pennsylvania School of Medicine

Katja G. Weinacht, M.D., Ph.D.
Assistant Professor of Pediatrics, Stanford University School of Medicine

John E. Wagner, M.D.
Distinguished McKnight Professor of Pediatrics, University of Minnesota

Giorgia Scapin, Ph.D.
Harvard Medical School
News
September
7
2022
March
15
2022
January
6
2022
January
5
2022
November
8
2021
National Institutes of Health (NIH) features the promise of Garuda Therapeutics technology
September
23
2021
September
23
2021
September
23
2021
September
23
2021
Join Us
We are seeking team members who share our passion for science, work ethic, and sense of urgency to improve patients’ lives.